المؤلفون: Lv A, Ding T, DeQiong, DaWaZhuoMa, Cai L, Zhang Y, Yin J, SeZhen, Lv Q

المصدر: Journal of Multidisciplinary Healthcare, Vol Volume 17, Pp 159-167 (2024)

مصطلحات موضوعية: pelvic floor disorder, tibet autonomous region, pelvic organ prolapse, urinary incontinence, overactive bladder symptoms, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.dovepress.com/prevalence-of-pelvic-floor-disorders-in-parous-women-from-the-tibet-au-peer-reviewed-fulltext-article-JMDH; https://doaj.org/toc/1178-2390

URL الوصول: https://doaj.org/article/dc16404927be4f2dbee5cbd7b918bee4

المؤلفون: Chuang YC, Lin PW, Lin HC, Chang CT, Friedman M, Salapatas AM, Lin CY

المصدر: Nature and Science of Sleep, Vol Volume 14, Pp 547-556 (2022)

مصطلحات موضوعية: snoring, obstructive sleep apnea, lower urinary tract symptoms, overactive bladder symptoms, osa surgery, transoral robotic surgery., Psychiatry, RC435-571, Neurophysiology and neuropsychology, QP351-495

وصف الملف: electronic resource

Relation: https://www.dovepress.com/effects-of-tors-osa-surgery-on-lower-urinary-tract-symptoms-overactive-peer-reviewed-fulltext-article-NSS; https://doaj.org/toc/1179-1608

URL الوصول: https://doaj.org/article/d6d3e61c453f43f3b138ec1bbeca5017

المؤلفون: Ibrahem Ismail Samaha, Kareem M. Taha, Islam Elbabouly, Maged Ali

المصدر: Société Internationale d’Urologie Journal, Vol 2, Iss 2, Pp 113-119 (2021)

مصطلحات موضوعية: vesicovaginal fistula, transvesical repair, lower urinary tract symptoms, overactive bladder symptoms score, urodynamic study, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: https://siuj.org/index.php/siuj/article/view/107/24; https://doaj.org/toc/2563-6499

URL الوصول: https://doaj.org/article/d61f12d81a5f4b5598a6a20343b6276f

المؤلفون: Dudding, T.C., Lehur, P.A., Sorensen, M., Engelberg, S., Bertapelle, M.P., Chartier-Kastler, E., Everaert, K., Van Kerrebroeck, P., Knowles, C.H., Lundby, L., Matzel, K.E., Munoz-Duyos, A., Rydningen, M.B., de Wachter, S.

المصدر: Dudding , T C , Lehur , P A , Sorensen , M , Engelberg , S , Bertapelle , M P , Chartier-Kastler , E , Everaert , K , Van Kerrebroeck , P , Knowles , C H , Lundby , L , Matzel , K E , Munoz-Duyos , A , Rydningen , M B & de Wachter , S 2021 , ' Reprogramming Sacral Neuromodulation for Sub-Optimal Outcomes: Evidence and Recommendations for Clinical Practice ' , Neuromodulation , vol. 24 , no. 7 , pp. 1247-1257 . https://doi.org/10.1111/ner.13494

مصطلحات موضوعية: Fecal incontinence, reprogramming, sacral neuromodulation, troubleshooting, urinary incontinence, OVERACTIVE BLADDER SYMPTOMS, MULTIPLE-SCLEROSIS PATIENTS, NERVE-STIMULATION, FOLLOW-UP, SINGLE-CENTER, VOIDING DYSFUNCTION, CONSTANT-CURRENT, MULTICENTER, EFFICACY

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/e4a94c17-c5b9-46df-beac-7b3a6ba0cc78
https://doi.org/10.1111/ner.13494

المؤلفون: Bora İrer, Volkan Şen, Ozan Bozkurt, Ömer Demir, Adil Esen

المصدر: Journal of Urological Surgery, Vol 5, Iss 3, Pp 180-187 (2018)

مصطلحات موضوعية: Overactive bladder symptoms, Prevalence, Risk factors, Urinary incontinence, Surgery, RD1-811, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: http://jurolsurgery.org/archives/archive-detail/article-preview/prevalence-and-possible-risk-factors-of-overactive/19594; https://doaj.org/toc/2148-9580

URL الوصول: https://doaj.org/article/da86961a375141ffbeba06d7a882c31b

المؤلفون: Nozomu Miyazaki, Ryota Katsura, Koki Hamada, Tatsuo Suzutani

المصدر: Nutrients; Volume 12; Issue 5; Pages: 1285

مصطلحات موضوعية: blueberry, Overactive Bladder Symptoms, Bladder Outlet Obstruction, rat model, functional food

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Phytochemicals and Human Health; https://dx.doi.org/10.3390/nu12051285

الاتاحة: https://doi.org/10.3390/nu12051285

المؤلفون: Keigo TAKAHASHI, Koshi SUMIGAWA, Sachiko OHASHI, Yuji KOIKE, 大橋 幸子, 小池 祐士, 澄川 幸志, 高橋 啓吾

المصدر: 理学療法科学 / Rigakuryoho Kagaku. 2021, 36(5):725

المؤلفون: Bhide, AA, Khullar, V, Swift, S, Digesu, GA

المصدر: 692 ; 683

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Obstetrics & Gynecology, Urology & Nephrology, CO2 laser, Erbium laser, Urinary incontinence, Prolapse, Menopause, STRESS URINARY-INCONTINENCE, VULVO-VAGINAL ATROPHY, ERBIUM-YAG LASER, FRACTIONAL CO2-LASER TREATMENT, OVERACTIVE BLADDER SYMPTOMS, GENITOURINARY SYNDROME, SEXUAL FUNCTION, TERM EFFICACY, WOMEN, Obstetrics & Reproductive Medicine, 1114 Paediatrics and Reproductive Medicine

Relation: International Urogynecology Journal and Pelvic Floor Dysfunction; http://hdl.handle.net/10044/1/74250; https://doi.org/10.1007/s00192-018-3844-7

الاتاحة: http://hdl.handle.net/10044/1/74250
https://doi.org/10.1007/s00192-018-3844-7

المساهمون: Yong Hyun Park, Tae Hyo Kim, Seung Wook Lee, Byung Ha Chung, Jin Seon Cho, Ji Youl Lee, Chung, Byung Ha

مصطلحات موضوعية: Adrenergic alpha-Antagonists / therapeutic use, Analysis of Variance, Cholinergic Antagonists / therapeutic use, Drug Therapy, Combination, Humans, Male, Middle Aged, Nocturia / drug therapy, Nocturia / physiopathology, Patient Reported Outcome Measures, Prospective Studies, Prostatic Hyperplasia / drug therapy, Prostatic Hyperplasia / physiopathology, Surveys and Questionnaires, Treatment Outcome, Urinary Bladder, Overactive / drug therapy, Overactive / physiopathology, Urination / physiology, benign prostatic hyperplasia, clinical outcomes, overactive bladder symptoms, patient-reported outcomes, treatment pattern

Relation: LUTS-LOWER URINARY TRACT SYMPTOMS; J03277; OAK-2017-1278; https://ir.ymlib.yonsei.ac.kr/handle/22282913/195824; T992017211; LUTS-LOWER URINARY TRACT SYMPTOMS, Vol.9(2) : 75-81, 2017-05

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/195824
https://doi.org/10.1111/luts.12112
https://onlinelibrary.wiley.com/doi/10.1111/luts.12112

المؤلفون: Oelke, Matthias, De Wachter, Stefan, Drake, Marcus J., Giannantoni, Antonella, Kirby, Mike, Orme, Susan, Rees, Jonathan, van Kerrebroeck, Philip, Everaert, Karel

المصدر: Oelke , M , De Wachter , S , Drake , M J , Giannantoni , A , Kirby , M , Orme , S , Rees , J , van Kerrebroeck , P & Everaert , K 2017 , ' A practical approach to the management of nocturia ' , International Journal of Clinical Practice , vol. 71 , no. 11 , 13027 . https://doi.org/10.1111/ijcp.13027

مصطلحات موضوعية: assessment of healthcare needs, desmopressin, expert opinion, morbidity, mortality, nocturia, pathophysiology, URINARY-TRACT SYMPTOMS, QUALITY-OF-LIFE, ORALLY DISINTEGRATING TABLET, PLACEBO-CONTROLLED TRIAL, STANDARDIZATION SUB-COMMITTEE, BENIGN PROSTATIC HYPERPLASIA, OVERACTIVE BLADDER SYMPTOMS, OBSTRUCTIVE SLEEP-APNEA, ADD-ON THERAPY, DOUBLE-BLIND

Relation: https://cris.maastrichtuniversity.nl/en/publications/a24f4327-0d67-41a5-9d37-2514052cb5ea

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/a24f4327-0d67-41a5-9d37-2514052cb5ea
https://doi.org/10.1111/ijcp.13027

المصدر: Neurourology and Urodynamics. 39(S3):104-112

مصطلحات موضوعية: urinary retention, phenotype, WOMEN, OVERACTIVE BLADDER SYMPTOMS, DEPRESSION, URETHRAL SPHINCTER, DYSFUNCTION, DETRUSOR OVERACTIVITY, DOUBLE-BLIND, Botulinum toxin, NEUROTOXIN, ONABOTULINUMTOXINA, overactive bladder, ABDUCENS MOTONEURONS

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od________83::07fa1a9d5ba5670bd59d56bb1884ce90
https://doi.org/10.1002/nau.24207

المؤلفون: Chuang, Yao-Chi, Lin, Pei-Wen, Lin, Hsin-Ching, Chang, Chun-Tuan, Friedman, Michael, Salapatas, Anna M, Lin, Chih-Yun

المصدر: All Other Contributions

مصطلحات موضوعية: OSA surgery, lower urinary tract symptoms, obstructive sleep apnea, overactive bladder symptoms, snoring, transoral robotic surgery, Otolaryngology, Surgery

Relation: https://institutionalrepository.aah.org/allother/207; https://libkey.io/libraries/1712/pmid/35387094

الاتاحة: https://institutionalrepository.aah.org/allother/207
https://doi.org/10.2147/NSS.S349807
https://libkey.io/libraries/1712/pmid/35387094

المؤلفون: M.A. Elbaset, Mohamad H. Zahran, Diaa-Eldin Taha, Abdelwahab Hashem, Ahmed S. El-Hefnawy

المصدر: Arab Journal of Urology

مصطلحات موضوعية: medicine.medical_specialty, Arabic, Urology, 030232 urology & nephrology, Urinary incontinence, urologic and male genital diseases, Voiding Dysfunction/Female Urology, Symptoms score, Over active bladder (OAB), 03 medical and health sciences, Bladder outlet obstruction, 0302 clinical medicine, Cronbach's alpha, Quality of life, Lower urinary tract symptoms, Internal medicine, medicine, Arabic validation, 030219 obstetrics & reproductive medicine, Lower urinary tract symptoms (LUTS), business.industry, questionnaire, medicine.disease, language.human_language, female genital diseases and pregnancy complications, Overactive bladder, quality of life (QOL), language, medicine.symptom, business, Overactive Bladder Symptoms Score (OABSS)

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d5fa7c0ff684bd79019eb6f81faa13
http://europepmc.org/articles/PMC6830271

المؤلفون: İNAN, DENİZ

المساهمون: Erel, C. Tamer, Carazo Fernandez, Luis Diego, Inan, Deniz, Makul, Melike

مصطلحات موضوعية: Stress urinary incontinence, TOT, TVT, Er:YAG laser, OVERACTIVE BLADDER SYMPTOMS, VAGINAL ERBIUM LASER, SHORT-TERM EFFICACY, GENITOURINARY SYNDROME, FEMALE STRESS, SEXUAL FUNCTION, YAG LASER, WOMEN, WEIGHT

Relation: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY; https://hdl.handle.net/11424/236366; WOS:000573032200022

الاتاحة: https://hdl.handle.net/11424/236366
https://doi.org/10.1016/j.ejogrb.2020.07.010

المؤلفون: Linda Cardozo, Thelma A. Lovick, Caroline Selai, Apostolos Apostilidis, Sachin Malde, Tom Marcelissen, Mohammad S. Rahnama'i

المصدر: Neurourology and urodynamicsREFERENCES. 39

مصطلحات موضوعية: medicine.medical_specialty, Basic science, Urology, 030232 urology & nephrology, URETHRAL SPHINCTER, 03 medical and health sciences, DOUBLE-BLIND, 0302 clinical medicine, Refractory, Botulinum toxin, medicine, Humans, Psychological testing, Botulinum Toxins, Type A, Intensive care medicine, 030219 obstetrics & reproductive medicine, Urinary retention, business.industry, Urinary Bladder, Overactive, WOMEN, OVERACTIVE BLADDER SYMPTOMS, Urinary Retention, medicine.disease, DEPRESSION, Comorbidity, DYSFUNCTION, DETRUSOR OVERACTIVITY, Administration, Intravesical, Phenotype, Treatment Outcome, Overactive bladder, Neuromuscular Agents, NEUROTOXIN, ONABOTULINUMTOXINA, overactive bladder, Neurology (clinical), medicine.symptom, Complication, business, ABDUCENS MOTONEURONS, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5b9d3c08f2577296ad209f4dffcc61
https://pubmed.ncbi.nlm.nih.gov/31692092

المؤلفون: Volkan Sen, Ahmet Adil Esen, Bora Irer, Omer Demir, Ozan Bozkurt

المصدر: Journal of Urological Surgery, Vol 5, Iss 3, Pp 180-187 (2018)

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urinary incontinence, lcsh:Surgery, lcsh:RD1-811, medicine.disease, urologic and male genital diseases, lcsh:Diseases of the genitourinary system. Urology, lcsh:RC870-923, humanities, female genital diseases and pregnancy complications, Overactive bladder symptoms, Overactive bladder, Risk factors, Internal medicine, medicine, Prevalence, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed6f4d8fc655dfdf4e0c4633972f1620
https://avesis.deu.edu.tr/publication/details/79977ea9-b7b7-4aab-ab30-eb1d541c1e4f/oai

المؤلفون: Anger, Jennifer T., Goldman, Howard B., Luo, Xuemei, Carlsson, Martin O., Chapman, Douglass, Zou, Kelly H., Russell, David, Ntanios, Fady, Esinduy, Canan B., Clemens, J. Quentin

مصطلحات موضوعية: benign prostatic hyperplasia, urgency incontinence, non‐surgical management, claims, anticholinergic medication, overactive bladder symptoms, urge incontinence, urinary urgency, urinary frequency, observational study, Internal Medicine and Specialties, Health Sciences

وصف الملف: application/pdf

Relation: Anger, Jennifer T.; Goldman, Howard B.; Luo, Xuemei; Carlsson, Martin O.; Chapman, Douglass; Zou, Kelly H.; Russell, David; Ntanios, Fady; Esinduy, Canan B.; Clemens, J. Quentin (2018). "Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States." Neurourology and Urodynamics 37(1): 213-222.; https://hdl.handle.net/2027.42/142147; Neurourology and Urodynamics; Goldman HB, Anger JT, Esinduy CB, et al. Real‐world patterns of care for the overactive bladder syndrome in the United States. Urology 2016; 87: 64 – 69.; Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology 2004; 64: 2 –6.; Heidler S, Mert C, Temml C, Madersbacher S. The natural history of the overactive bladder syndrome in females: a long‐term analysis of a health screening project. Neurourol Urodyn 2011; 30: 1437 –1441.; Nitti VW. Clinical impact of overactive bladder. Rev Urol 2002; 4: S2 –S6.; Sarma AV, Wei JT. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms. N Engl J Med 2012; 367: 248 –257.; Irwin DE, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol 2009; 56: 14 – 20.; Maserejian NN, Chen S, Chiu GR, et al. Incidence of lower urinary tract symptoms in a population‐based study of men and women. Urology 2013; 82: 560 – 564.; Filson CP, Hollingsworth JM, Clemens JQ, Wei JT. The efficacy and safety of combined therapy with alpha‐blockers and anticholinergics for men with benign prostatic hyperplasia: a meta‐analysis. J Urol 2013; 190: 2153 –2160.; Wagg A, Compion G, Fahey A, Siddiqui E. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience. BJU Int 2012; 110: 1767 –1774.; Shortridge E, Donatucci C, Donga P, Marcus M, Wade RL. Adherence and persistence patterns in medication use among men with lower urinary tract symptoms/benign prostatic hyperplasia. Am J Mens Health 2015; 11: 164 – 169.; Kaplan SA, Roehrborn CG, Chancellor M, Carlsson M, Bavendam T, Guan Z. Extended‐release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score. BJU Int 2008; 102: 1133 –1139.; Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327 –336.; Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2008; 179: S75 –S80.; Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015; 22: 1 –6.; Anger JT, Saigal CS, Wang M, Yano EM. Urologic diseases in America project. Urologic disease burden in the United States: veteran users of department of veterans affairs healthcare. Urology 2008; 72: 37 –41. Discussion 41.; Delaney JAC, Seeger J. Sensitivity analysis. In: Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, eds. Developing a Protocol for Observational Comparative Effectiveness Research: A User’s Guide. Rockville (MD): Agency for Healthcare Research and Quality 2013.; McVary KT, Roehrborn CG, Avins AL, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011; 185: 1793 –1803.; Gormley EA, Lightner DJ, Faraday M, Vasavada SP. American Urological A, Society of Urodynamics FPM. Diagnosis and treatment of overactive bladder (non‐neurogenic) in adults: aUA/SUFU guideline amendment. J Urol 2015; 193: 1572 –1580.; Roehrborn C. Benign prostatic hyperplasia and lower urinary tract symptom guidelines. Can Urol Assoc J 2012; 6: S130 –S132.; Clemens JQ, Goldman HB, Zou KH, et al. Patterns of care for newly diagnosed benign prostatic hyperplasia in the United States. J Urol 2016; 196: 173 –178.

الاتاحة: https://hdl.handle.net/2027.42/142147
https://doi.org/10.1002/nau.23276

المؤلفون: Tahseen, Samina

مصطلحات موضوعية: Bladder Pain, Chronic Urinary Retention, Double Incontinence, Overactive Bladder Symptoms, Sacral Nerve Stimulation, Urinary Incontinence

Relation: http://hdl.handle.net/20.500.12904/1293

الاتاحة: https://hdl.handle.net/20.500.12904/1293

المؤلفون: Sakalis, Vasileios I., Karavitakis, Markos, Bedretdinova, Dina, Bach, Thorsten, Bosh, J. L. H. Ruud, Gacci, Mauro, Gratzke, Christian, Herrmann, Thomas R., Madersbacher, Stephan, Mamoulakis, Charalampos, Tikkinen, Kari A. O., Gravas, Stavros, Drake, Marcus J.

المساهمون: Clinicum, Urologian yksikkö, Department of Public Health, University of Helsinki, HUS Abdominal Center

مصطلحات موضوعية: ORALLY DISINTEGRATING TABLET, CONTINENCE-SOCIETY, LUTS, IPSS, JAPANESE PATIENTS, DESMOPRESSIN, TAMSULOSIN HYDROCHLORIDE, BENIGN PROSTATIC HYPERPLASIA, Guidelines, OVERACTIVE BLADDER SYMPTOMS, PLACEBO-CONTROLLED TRIAL, 3126 Surgery, anesthesiology, intensive care, radiology, CLINICAL-TRIAL, DOUBLE-BLIND, 3121 General medicine, internal medicine and other clinical medicine, Nocturia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1593::18c4e7e76eb57d6015d26c0543209f3f
http://hdl.handle.net/10138/298078

المؤلفون: Sakalis, Vasileios I., Karavitakis, Markos, Bedretdinova, Dina, Bach, Thorsten, Bosh, J. L. H. Ruud, Gacci, Mauro, Gratzke, Christian, Herrmann, Thomas R., Madersbacher, Stephan, Mamoulakis, Charalampos, Tikkinen, Kari A. O., Gravas, Stavros, Drake, Marcus J.

المساهمون: Clinicum, Urologian yksikkö, Department of Public Health, University of Helsinki, HUS Abdominal Center

مصطلحات موضوعية: Nocturia, LUTS, Desmopressin, IPSS, Guidelines, BENIGN PROSTATIC HYPERPLASIA, ORALLY DISINTEGRATING TABLET, OVERACTIVE BLADDER SYMPTOMS, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, TAMSULOSIN HYDROCHLORIDE, CONTINENCE-SOCIETY, JAPANESE PATIENTS, CLINICAL-TRIAL, Surgery, anesthesiology, intensive care, radiology, General medicine, internal medicine and other clinical medicine

وصف الملف: application/pdf

Relation: Marcus J. Drake certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: Bach has received speaker honoraria from Cook Urology, Boston Scientific, GSK, and Richard Wolf, participates in a trial for Ipsen, and has received fellowships and travel grants from Lisa Laser; Drake has received speaker honoraria from Allergan, Astellas, and Ferring. He has received grants and research support from Allergan, Astellas, and Ferring; Gacci is a company consultant for Bayer, Ibsa, GSK, Lilly, Pfizer, and Pierre Frabre. He participates in trials for Bayer, Ibsa, and Lilly, and has received travel grants and research support from Bayer, GSK, and Lilly; Gratzke is a company consultant for Astellas Pharma, Bayer, Dendreon, Lilly, Rottapharm-Madaus, and Recordati. He has received speaker honoraria from AMS, Astellas Pharma, Pfizer, GSK, Steba, and Rottapharm-Madaus, and travel grants and research support from AMS, DFG, Bayer Healthcare Research, the EUSP, MSD, and Recordati; Maderbacher is a company consultant for Astellas, GSK, Lilly, and Takeda, and receives speaker honoraria from Astellas, Bohringer Ingelheim, GSK, Lilly, MSD, and Takeda. Mamoulakis is a company consultant for Astellas, GSK, and Teleflex, and has received speaker honoraria from Elli Lilly. He participates in trials for Astellas, Elli Lilly, Karl Storz Endoscope, and Medivation, and has received fellowships and travel grants from Ariti, Astellas, Boston Scientific, Cook Medical, GSK, Janssen, Karl Storz Endoscope, Porge-Coloplast, and Takeda. Gravas has received grants or research support from Pierre Fabre Medicament and GSK, travel grants from Angelini Pharma Hellas, Astellas, GSK, and Pierre Fabre Medicament, and speaker honoraria from Angelini Pharma Hellas, Pierre Fabre Medicament, Lilly, and GSK, and is a consultant for Astellas, Pierre Fabre Medicament, and GSK. Herrmann declares Karl Storz GmBH, honoraria, financial support for attending symposia, financial support for educational programs, consultancy, advisory, royalties: Boston Scientific AG honoraria, financial support for attending symposia, financial support for educational programs, consultancy, advisory Board; LISA Laser OHG AG Honoraria, financial support for attending symposia, financial support for educational programs; Ipsen Pharma Honoraria, financial support for attending symposia, advisory board; Bosch has received grants or research support from GSK and Astellas, speaker honoraria from GSK, AstraZeneca, Allergan, and FerringAG. He participates in trials for Astellas and is a consultant for Astellas, Eli-Lilly, and Ferring AG.; Sakalis , V I , Karavitakis , M , Bedretdinova , D , Bach , T , Bosh , J L H R , Gacci , M , Gratzke , C , Herrmann , T R , Madersbacher , S , Mamoulakis , C , Tikkinen , K A O , Gravas , S & Drake , M J 2017 , ' Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms : Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms ' , European Urology , vol. 72 , no. 5 , pp. 757-769 . https://doi.org/10.1016/j.eururo.2017.06.010; ORCID: /0000-0002-1389-8214/work/52696077; http://hdl.handle.net/10138/298078; c3a364b4-0f6d-4afc-a46f-941402c8224e; 85021831661; 000412685300029

الاتاحة: http://hdl.handle.net/10138/298078